Protein and Peptide Drugs: A Brief Review

Peptides and proteins continue to grow in popularity for their potential use in current drug therapy and protein drug market will reach $ 55.7 billion by the end of 2011. Protein and Peptide products for therapeutic use include a very diverse range of product as Hormones, Growth factors, cytokines, vaccines and Monoclonal antibodies. Biotechnology has given many ways for the production of protein based drugs as Hybridoma cell technology, Recombinant DNA technology and transgenic animals. Different Technologies are developed for the improved delivery of protein therapeutics but there are number of safety issues, relating to protein products that differ from those raised by low molecular weight products.